Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.76 -0.02 (0.14%)
Previous Close $14.78    52 Week High $5.58 
Open $14.84    52 Week Low $3.60 
Day High $14.92    P/E N/A 
Day Low $14.66    EPS $0.00 
Volume 17,276,591       

SANOFI (NASDAQ: SNY) Delayed: 43.72 -0.06 (0.14%)
Previous Close $43.78    52 Week High $44.76 
Open $43.51    52 Week Low $36.81 
Day High $43.80    P/E N/A 
Day Low $43.24    EPS $0.00 
Volume 2,719,197       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(AMEX: ZLDPY) Delayed: 9.31 --0 (-0%)
Previous Close $9.31    52 Week High $ 
Open $9.31    52 Week Low $ 
Day High $9.31    P/E N/A 
Day Low $9.31    EPS $ 
Volume 20,582,182